Login / Signup

Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy.

Lingyan YuZhiliang WangZhenwei YuJianhua FengHaibin Dai
Published in: Annals of clinical and translational neurology (2021)
Allergic reactions are common reasons for withdrawal of oxcarbazepine treatment in patients with epilepsy. However, some patients are not responsive to other antiseizure medications. Herein, two pediatric patients with epilepsy and allergic to oxcarbazepine to whom oxcarbazepine therapy was successfully reintroduced are described. The reintroduction strategy used in this study was simple, feasible, and suitable for the reintroduction of oxcarbazepine in pediatric patients with epilepsy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • allergic rhinitis
  • prognostic factors
  • temporal lobe epilepsy
  • cancer therapy
  • combination therapy